Humans infected with the dimorphic fungus Blastomyces dermatitidis develop strong T-lymphocyte responses to WI-1, an immunodominant antigen that has been shown to elicit protective immunity in mice. In the present study, the T-cell epitopes of WI-1 and human leukocyte antigen (HLA) restricting elements that display them were investigated. Peripheral blood mononuclear cells (PBMC) from 37 patients with a confirmed history of blastomycosis were tested for a response to WI-1 in primary proliferation assays; PBMC from 35 (95%) responded. Six patients whose PBMC proliferated strongly in response to WI-1 (defined as a stimulation index greater than 50) were tested further for responses to subcloned, recombinant fragments of the antigen. These patients responded chiefly to sequences within the N terminus and the 25-amino-acid tandem repeat. Cloned CD4 ؉ T cells from an infected individual were used to delineate more precisely the peptide epitopes in the fragments and HLA restricting elements that present them. A majority of the T-cell clones recognized an epitope spanning amino acids 149 to 172 within the N terminus, displayed by HLA-DR 15. A minority of the clones, which have been shown to perform a cytolytic function in vitro, recognized an epitope in the tandem repeat displayed by HLA-DPw4, an uncommon restricting element. Tandem repeat epitopes required display by the  chain of DPw4 heterodimers. Thus, human T cells with different functions in vitro also recognize distinct regions of WI-1, raising the possibility that HLA restricting elements that present them could modulate immunity during blastomycosis by selection and display of WI-1 peptides.Blastomyces dermatitidis is a dimorphic fungus that causes disease in both healthy and immunodeficient hosts. The fungus is endemic to the Mississippi and Ohio River valleys and northern Wisconsin. The spectrum of infection includes asymptomatic disease, acute or chronic pneumonia, and disseminated disease, especially in immunodeficient patients, who are at higher risk for developing widely disseminated blastomycosis (19,20).The growing frequency of invasive fungal diseases and the challenge of treating them have stimulated interest in developing ways to prevent fungal infections. The immunodominant and protective antigens for many fungal pathogens have not been elucidated and are actively being investigated (7). For B. dermatitidis, we previously described a 120-kDa protein antigen, WI-1, expressed abundantly on yeast phase cells. WI-1 is an adhesin that binds the fungus to receptors on human macrophages (17) and confers virulence on the yeast (2) and is also an immunodominant antigen that stimulates humoral and cellmediated immune responses during natural infection (11,12). Immunization of mice with WI-1 significantly enhances their resistance against a lethal pulmonary challenge with B. dermatitidis (25), an indication that anti-WI-1 immune responses benefit the host. Thus, WI-1 may serve as a candidate for developing a vaccine against blastomycosis.Studies of mice and ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.